1. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose inter-leukin-2 alone;Rosenberg;N. Engl. J. Med.,1987
2. Successful immunotherapy for malignant hemangio-endothelioma using recombinant interleukin-2;Masuzawa;Jpn. J. Dermatol,1988
3. Effect of recombinant human interleukin-2 (rIL-2) on the growth of murine endothelial cell lines, and cytotoxic activity of nonspecific killer cells induced by rIL-2 against the endothelial cell lines;Naruo;Jpn. Pharmacol. Ther.,1989
4. Effect of recombinant human interleukin-2(rIL-2) on the growth of murine endothelial cell lines in vivo;Ootsu;Jpn. J. Pharmacol Ther.,1989
5. Translation of interleukin-2 mRNA from human peripheral blood leukocytes in Xenopus oocytes;Hinuma;Biochem. Biophys. Res. Commun.,1982